ClinConnect ClinConnect Logo
Search / Trial NCT05099432

The CARMA Technique Study

Launched by PRINCESS ALEXANDRA HOSPITAL, BRISBANE, AUSTRALIA · Oct 18, 2021

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

The CARMA Technique Study is a clinical trial that aims to improve how doctors remove polyps from the colon, which are growths that can sometimes lead to colorectal cancer. The study is testing a new method called the Cap Assisted Resection Margin Assessment (CARMA) technique. This technique helps doctors check that they have completely removed the polyp by using advanced imaging tools during the procedure. The goal is to reduce the chances of polyps growing back after they have been removed, which is a common issue that can lead to further health problems.

To participate in this study, individuals must have colonic polyps and meet certain criteria. For example, participants can have up to two polyps removed, but they should not have small polyps (less than 10mm) that have already been completely removed during a previous procedure. If you join the study, you can expect to undergo a standard procedure to remove the polyp while the doctors use the new CARMA technique to ensure it is done safely and effectively. This trial is open to people aged 18 and older, regardless of gender, and is currently looking for participants. If you have any questions about your eligibility or the study itself, it's a good idea to talk to your doctor.

Gender

ALL

Eligibility criteria

  • Patients with colonic polyps will be considered following below criteria
  • Inclusion Criteria:
  • - any polypectomy (though only a maximum of two polyps from one individual participant)
  • Exclusion Criteria:
  • polyps less than 10mm which were resected under endoscopic view with a definite \> 1mm clear margin
  • scar site recurrence polyps
  • polyps with endoscopic evidence of invasion
  • pedunculated polyps
  • pseudopolyps
  • participants who will not be available for follow up endoscopy

About Princess Alexandra Hospital, Brisbane, Australia

Princess Alexandra Hospital (PAH) in Brisbane, Australia, is a leading tertiary healthcare facility renowned for its commitment to innovative clinical research and patient care. As a prominent clinical trial sponsor, PAH collaborates with multidisciplinary teams to advance medical knowledge and improve treatment outcomes across various specialties. The hospital is equipped with state-of-the-art facilities and a diverse patient population, enabling researchers to conduct high-quality, ethically sound trials that contribute significantly to the advancement of healthcare both locally and globally. PAH’s dedication to excellence in research is underscored by its adherence to rigorous regulatory standards and a focus on patient safety and wellbeing.

Locations

Woolloongabba, Queensland, Australia

Patients applied

0 patients applied

Trial Officials

Alexander Huelsen, MD

Principal Investigator

Princess Alexandra Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials